Active, Not Recruiting
Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer
NCT03672773
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +9 more
- Locations
-
- CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center Bakersfield, California, United States
- St. Joseph Heritage Healthcare Fullerton, California, United States
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- Orlando Health, Inc. d/b/a Orlando Health UF Health Center Orlando, Florida, United States